| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -337.00 | 0.00 | Sale to Issuer | - | 33.33k | -1.00% |
| 2026-06-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -81.00 | 0.00 | Sale to Issuer | - | 5.61k | -1.42% |
| 2026-06-01 | Ms. Lindsey McGowanVP, Chief Compliance & Quality Officer | -198.00 | 0.00 | Sale to Issuer | - | 5.09k | -3.75% |
| 2026-06-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -208.00 | 0.00 | Sale to Issuer | - | 10.50k | -1.94% |
| 2026-06-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -768.00 | 0.00 | Sale to Issuer | - | 12.73k | -5.69% |
| 2026-06-01 | Mr. Kenneth E. KohlerSenior VP & GM of AST | -109.00 | 0.00 | Sale to Issuer | - | 9.53k | -1.13% |
| 2026-06-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -673.00 | 0.00 | Sale to Issuer | - | 12.21k | -5.22% |
| 2026-06-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -1.25k | 0.00 | Sale to Issuer | - | 49.84k | -2.45% |
| 2026-06-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -99.00 | 0.00 | Sale to Issuer | - | 8.21k | -1.19% |
| 2026-03-05 | Ms. Cynthia L. FeldmannIndependent Director | -3.10k | 262.99k | Derivative Exercise and Sale | 152.32 - 237.21 | 9.37k | - |
| 2025-11-21 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -5.01k | 669.96k | Derivative Exercise and Sale | 114.22 - 262.00 | 10.71k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3.54k | 266.07k | Derivative Exercise and Sale | 182.22 - 258.03 | 5.70k | - |
| 2025-11-18 | Mr. Renato G. TamaroVP & Corporate Treasurer | -1.50k | 386.64k | 売り | 257.76 | 5.70k | -20.85% |
| 2025-11-11 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -15.00k | 2.93M | Derivative Exercise and Sale | 69.72 - 265.14 | 33.67k | - |
| 2025-10-06 | Mr. Daniel A. CarestioPresident, CEO & Director | -159.00 | 38.45k | 売り | 241.82 | 51.10k | -0.31% |
| 2025-10-01 | Mr. Renato G. TamaroVP & Corporate Treasurer | -26.00 | 0.00 | Sale to Issuer | - | 7.20k | -0.36% |
| 2025-10-01 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -91.00 | 0.00 | Sale to Issuer | - | 33.67k | -0.27% |
| 2025-10-01 | Mr. Cary L. MajorsSenior VP & President of Healthcare | -303.00 | 0.00 | Sale to Issuer | - | 13.49k | -2.20% |
| 2025-10-01 | Ms. Mary Clare FraserSVP & Chief HR Officer | -207.00 | 0.00 | Sale to Issuer | - | 12.88k | -1.58% |
| 2025-10-01 | Ms. Julia K. MadsenSenior VP & GM of Life Sciences | -52.00 | 0.00 | Sale to Issuer | - | 10.71k | -0.48% |
| 2025-10-01 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -39.00 | 0.00 | Sale to Issuer | - | 8.30k | -0.47% |
| 2025-10-01 | Mr. Daniel A. CarestioPresident, CEO & Director | -130.00 | 0.00 | Sale to Issuer | - | 51.26k | -0.25% |
| 2025-08-20 | Mr. Renato G. TamaroVP & Corporate Treasurer | -3.20k | 327.42k | Derivative Exercise and Sale | 147.05 - 249.24 | 7.22k | - |
| 2025-08-13 | Mr. Richard Carroll BreedenIndependent Director | 4.11k | 263.25k | Derivative Exercise and Retained Stock | 64.05 | 36.66k | 12.63% |
| 2025-08-11 | Dr. Mohsen M. SohiIndependent Chairman of the Board | -4.11k | 731.21k | Derivative Exercise and Sale | 64.05 - 241.96 | 22.36k | - |
| 2025-08-11 | Ms. Cynthia L. FeldmannIndependent Director | -3.50k | 844.25k | Derivative Exercise and Sale | 241.56 | 9.37k | - |
| 2025-08-11 | Ms. Karen L. BurtonSenior VP, CFO & CAO | -7.90k | 1.01M | Derivative Exercise and Sale | 114.22 - 241.73 | 5.99k | - |
| 2025-06-13 | Mr. John Adam ZangerleSenior VP, General Counsel & Secretary | -1.98k | 477.58k | 売り | 240.63 - 241.61 | 33.76k | -5.53% |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。